NCT03454035 2025-09-11
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
UNC Lineberger Comprehensive Cancer Center
Phase 1 Recruiting
Clinical Trials
6 trialsNCT04720768 2024-01-05
CELEBRATE
Peter MacCallum Cancer Centre, Australia
Phase 1/2 Unknown
NCT01037790 2021-03-11
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT02065063 2018-06-01
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT03454919 2018-03-06
Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT02202200 2016-04-18
OPTIMUM
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Unknown